Getting R&D Right: NASEM Panel Weighs Strategies To Match Innovation With Disease Burden

 
• By Cole Werble

A US National Academy of Sciences, Engineering and Medicine panel is considering whether biomedical innovation is aligned with public health needs. The resulting report could impact FDA and federal policy on rare disease and research and development incentives.

incentives aligned
Incentives exist, but are not coordinated, Scott Howell said during a NASEM meeting on the subject. • Source: Shutterstock

More from R&D

More from Pink Sheet